Tuesday, 17 Sep 2019


Date Typesort ascending Title Save
06 Nov 2017 Social RT @psufka: Great work! Shrinking lung syndrome in lupus is condition we should all be aware of to have on our differential. #ACR17 @rheumn…
16 Feb 2017 Social RT @DrRachelTate: Low dose IL-2 possible tx for SLE. #rwcs2017 @RWCSmtg @RheumNow https://t.co/de5cduW6v0
18 May 2015 Social Autophagy is housekeeping process wherein degraded cellular stuff is disposed by lysosomes. Is it defective in lupus? http://t.co/CAXtWVMcjZ
25 May 2017 Social RT @AJKDonline: #OpenAccess Induction & Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Meta-Analysis https://t…
31 Oct 2017 Social 18FFDG-PET superior to clinical scoring in Dx of PMR (pre-pred) w/ sensitivity 85%, specificity 87%, PPV 93% NPV 74% https://t.co/11ltSQLkT9
16 Jan 2019 Social Who thought this was possible? Numbers suggest this is rare. Tis wrong to use this to forge ahead with an unlikely PMR dx in the face of a normal CRP/ESR; but will you go so far as to order the expensive FDG-PET? https://t.co/RTkiUXO7lX
07 Nov 2017 Social RT @WShergy: The forms of exercise most associated with Rhabdomyalysis. acr2017 @rheumnow#2174 https://t.co/hz62eRhyAi
02 Nov 2015 Social Check out the cool, free, slide download on Lupus Skin Disease from RheumNow. https://t.co/P0418gbjDf
26 Jul 2016 Social CHMP has recommended abatacept for 1st line use (before MTX) in moderate to severe RA. EMA to consider approval https://t.co/kXyD1cXKbO
21 Jan 2018 Social RT @Lupusdoc: https://t.co/ElqvrKfXDy Steroid use in SLE: highly variable dosing across centres and no downward trend in use over the past…
29 Apr 2017 Social RT @DrRachelTate: Key phenotypic features of Sjogrens Syndrome and the new classification criteria. A. Baer, MD @RheumNow #SOTA2017 https:/…
14 Jun 2018 Social RT @RonanTKavanagh: “Glucocorticoids are the elephant in the room” where treatment of GCA are concerned. (In relation to side effects). Dr…
06 Apr 2017 Social Dr Torgerson Complement deficiency in SLE: C2 40% homozytotes get lupus GN; C4 - 75% get GN; C1q/r/s def 90% get SLE or GN, usually young
11 Sep 2019 Social A changing spectrum of Hydralazine induced lupus? Several reports showing cases of the usual (pleuropericarditis, arthriti + Skin, +ANA) but also the unusual (ANA neg, ANCA/PR3/MPO positive, Bx proven nephritis and +ACL, +dsDNA) https://t.co/WgOZ4NdrUS https://t.co/eQYWzFfq3F
16 Nov 2016 Social RT @rachelthuston: Key US findings in GCA per #OMERACT #ACR16 @RheumNow https://t.co/Dm1Sr0qOkf https://t.co/9jjzZnozfZ
30 Apr 2016 Social Late onset SLE (>50yrs) patients have less cutaneous dz (malar rash, photosensitivity, livedo) but more Sicca Sx https://t.co/TuqomEgSIa
04 Nov 2017 Social RT @isa75012: Another reason to remember Asherson. Name author on lots of research on APS and CAPS. #ACR17 https://t.co/JmAIo8G0KN
10 Nov 2017 Social RT @isa75012: PulmHTN and ILD now leading cause of death in #scleroderma #GR https://t.co/6q2i9yWdB8
25 Oct 2018 Social RT @CCalabreseDO: checkpoint inhibitor-related myositis has unique phenotype - myocarditis, myasthenia gravis-like symptoms abstract #2976…
25 Nov 2015 Social RT @DrPetryna: @RheumNow Vitamin D levels may predict cognitive impairment in patients with #SLE https://t.co/oDI3GtUMvj